HIF1A and metabolic dysfunction-associated steatotic liver disease: As a particularity, HIF-1α levels are also increased in the brains and livers of patients with NAFLD and in those with obstructive sleep apnea, aggravating the progression of liver disease and chronic intermittent hypoxia [25,26].